ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth
03. Oktober 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma post strong Q2 results
ViaDerma Completes First Shipment of 500,000 Units to Nigeria
10. September 2024 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a specialty pharmaceutical company known for developing innovative transdermal drug delivery systems, is pleased to...
ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria
13. August 2024 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a leader in innovative wound care solutions, is excited to announce that a shipment of 500,000 units of its flagship...
ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
01. August 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma announces strategic new agreements to move forward its global expansion.
ViaDerma Provides Highlights of Quarterly Financial Report
06. Juni 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma provides an update on their most recent quarterly financial report
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
24. Oktober 2023 10:30 ET
|
ViaDerma, Inc.
LOS ANGELES, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce several new and exciting business updates for current and prospective shareholders,...
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More
06. Juli 2023 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is very pleased to announce several exciting business updates for current and prospective shareholders, partners, and...
ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
16. März 2023 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 16, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce that the company has recently submitted their application for their planned minoxidil hair...
ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product
08. März 2023 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 08, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce their plans to launch a new hair regrowth product using Minoxidil (topical route). The company...
ViaDerma Provides an Update on Current & Future Business Activities
02. März 2023 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 02, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to provide an update on current business activities. ViaDerma has expanded its licensing agreement with a...